Shanghai Model Organisms Center, Inc. (SHA:688265)

Market Cap	3.13B -33.3%
Revenue (ttm)	432.55M +11.9%
Net Income	33.09M +79.6%
EPS	0.49 +128.9%
Shares Out	75.62M
PE Ratio	84.80
Forward PE	n/a
Dividend	0.13 (0.30%)
Ex-Dividend Date	Jul 13, 2026

Volume	2,543,241
Open	40.92
Previous Close	41.40
Day's Range	38.93 - 41.40
52-Week Range	30.36 - 63.50
Beta	0.33
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2026

About SHA:688265

Shanghai Model Organisms Center, Inc. engages research and development, production, sale, and related technical services of genetically modified animal models. It uses model organisms, such as mice, rats, zebrafish, and nematodes as carriers which uses gene editing technology to introduce or delete target DNA fragments. The company offers toolbox of mice; disease mice, such as rare, infectious, and nervous system diseases, cardio-metabolic, autoimmune, and spontaneous tumor; and target humanized knockins, which includes tumor targets, immune ch...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2000
• Employees: 848
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688265

Financial Performance

In 2025, SHA:688265's revenue was 421.02 million, an increase of 10.44% compared to the previous year's 381.24 million. Earnings were 31.44 million, an increase of 383.97%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 2, 2026

Data Sources Report a data error